The clean category word is almost always taken. This one isn’t. EPIGENETIC.COM is the bare single-word .com for epigenetics — no prefix, no suffix, no dash — offered directly by its owner.
Buy-now $14,888 · or about $1,241/mo over 12 months · owner-direct
A clean single-word .com naming an established scientific category almost never comes to market. I own this one, and I’m offering it directly.
No broker, no marketplace, no commission folded into the number. EPIGENETIC.COM is the bare category word — the version every team in the field works around because it was never available. It is now, and it is meant to go to an operator who will build on it.
Sarah WilliamOwner · EPIGENETIC.COM
Across epigenetics, almost every company is built on a workaround — an Epi- prefix, a -Dx or -labs suffix, a dash, an added letter. The reason is the same in every case: the bare category word was never on the market.
I hold that word, and I’m selling it myself. I’d rather place EPIGENETIC.COM with a team already doing the work than watch it sit on a shelf. That is why the ask is four figures — a price meant to move the name to the right owner, not to anchor a long negotiation.
This is not an auction and not a marketplace listing. It is a direct, private sale. If a cleaner brand — for a methylation-data portal, a product line, a clinical sub-brand, or the whole company — is anywhere on your roadmap, this is the window.
The full picture — the scarcity case, the category numbers, and the buy-now and monthly terms — comes straight back to you. Send an offer or a question. Sarah William · Owner, EPIGENETIC.COM
A brand built on a workaround spends every quarter teaching the market a name that isn’t quite the category word. The clean word ends that work in one move.
There is no second copy of this name, because there is no second spelling of the category. EPIGENETIC.COM is the exact, unqualified .com for epigenetics — the word the entire field already uses, with nothing bolted on.
Look at how companies have solved the problem until now. Cambridge Epigenetix built on a dashed domain and ultimately rebranded to biomodal after more than $160M raised. EpigenDx carries the Epigen- root with a -Dx tacked on. EpiCypher pairs Epi- with a coined second word. Each is a strong company; each pays a small tax every time someone has to spell the name back or ask what it means.
EPIGENETIC.COM is the version with no tax. It doesn’t have to replace anyone’s primary site. It can anchor a methylation-data portal, a product line, a clinical sub-brand, or a single campaign — a clean front door for the initiative that deserves one.
One owner holds it. The sale is direct — no broker, no third party, no marketplace markup folded into the price.
“The most expensive thing in branding is the word everyone in your field already uses. Here, that word is for sale exactly once.”
The argument for EPIGENETIC.COM rests on scarcity and category fit — named data, not a megasale anchor it doesn’t need.
No claim that EPIGENETIC.COM is worth a megasale figure. The case is narrow and true: a clean single-word .com in an established scientific category rarely comes to market, and this one is offered owner-direct at a four-figure price.
Prefer to name your own number? Offers are welcome — even a low one starts the conversation, and the form below reaches the owner directly.
Send your offer or a question below and it reaches me directly. Every genuine inquiry gets the scarcity case, the category numbers, and the buy-now and monthly terms in full — in writing, owner to buyer.
Thank you — your message has reached me directly and you’ll hear back shortly. For anything urgent, reach me at contact@epigenetic.com.